Additional Type 1 Diabetes Research Studies Being Conducted by the ITN
EXTEND Preserving Beta-Cell Function with Tocilizumab in New-Onset Type 1 Diabetes
The EXTEND study is a clinical research study testing whether tocilizumab (Actemra ®) can protect remaining beta cells in individuals recently diagnosed with type 1 diabetes and extend the ability to naturally produce insulin.
For more information about the ITN and other clinical trials, please visit immunetolerance.org.